Peptic ulcer laboratory tests: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(38 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Peptic ulcer}}
{{Peptic ulcer}}
{{CMG}}; {{AE}} {{GRN}} {{MKK}}
{{CMG}}; {{AE}} {{MKK}} {{GRN}}  


==Overview==
==Overview==
Lab tests for the diagnosis of [[peptic ulcer]] can be divide into invasive  and non-invasive tests. The most common invasive  tests include rapid urease testing, histology, and culture and [[Polymerase Chain Reaction]] ([[PCR]]).  The most common non-invasive test include [[urea breath test]], [[antibody]] testing, and monoclonal fecal [[antigen]].
There is no specific diagnostic laboratory test for [[peptic ulcer disease]] but in the patient with the history of [[peptic ulcer disease]], the laboratory test is used to rule out [[bleeding]] and to document the status of eradication therapy and to test refractory [[ulcers]].


==Laboratory Findings==
==Initial Laboratory Studies==
 
*There are no diagnostic laboratory findings associated with [[peptic ulcer disease]]
*Approach of patients <55 years, depending of the ''H. pylori'' (''H. pylori'') prevalence (≥10%):
*If there is the history of [[peptic ulcer disease]] then following laboratory test are done:<ref name="pmid10086037">{{cite journal |vauthors=Graham DY, Rakel RE, Fendrick AM, Go MF, Marshall BJ, Peura DA, Scherger JE |title=Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis |journal=Postgrad Med |volume=105 |issue=3 |pages=113–6, 121–3, 127–8 passim |year=1999 |pmid=10086037 |doi=10.3810/pgm.1999.03.594 |url=}}</ref><ref name="pmid2216988">{{cite journal |vauthors=Rosen SD, Rogers AI |title=Clinical recognition and evaluation of peptic ulcer disease |journal=Postgrad Med |volume=88 |issue=5 |pages=42–7,51,55 |year=1990 |pmid=2216988 |doi= |url=}}</ref><ref name="pmid25955624">{{cite journal |vauthors=Fashner J, Gitu AC |title=Diagnosis and Treatment of Peptic Ulcer Disease and H. pylori Infection |journal=Am Fam Physician |volume=91 |issue=4 |pages=236–42 |year=2015 |pmid=25955624 |doi= |url=}}</ref><ref name="pmid100860372">{{cite journal |vauthors=Graham DY, Rakel RE, Fendrick AM, Go MF, Marshall BJ, Peura DA, Scherger JE |title=Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis |journal=Postgrad Med |volume=105 |issue=3 |pages=113–6, 121–3, 127–8 passim |year=1999 |pmid=10086037 |doi=10.3810/pgm.1999.03.594 |url=}}</ref><ref name="pmid26354049">{{cite journal |vauthors=Chung CS, Chiang TH, Lee YC |title=A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers |journal=Korean J. Intern. Med. |volume=30 |issue=5 |pages=559–70 |year=2015 |pmid=26354049 |pmc=4578017 |doi=10.3904/kjim.2015.30.5.559 |url=}}</ref><ref name="pmid21263414">{{cite journal |vauthors=Mehmedović-Redzepović A, Mesihović R, Prnjavorac B, Kulo A, Merlina K |title=Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pump inhibitors |journal=Med Glas (Zenica) |volume=8 |issue=1 |pages=151–7 |year=2011 |pmid=21263414 |doi= |url=}}</ref>
**Test and treat for ''H. pylori'' using a validated noninvasive test and a trial of acid suppression if eradication is successful but symptoms do not resolve '''OR'''
**[[Complete blood count]]
**Empiric trial of acid suppression with a proton pump inhibitor (PPI) for 4-8 weeks.<ref name="pmid16181387">{{cite journal| author=Talley NJ, Vakil N, Practice Parameters Committee of the American College of Gastroenterology| title=Guidelines for the management of dyspepsia. | journal=Am J Gastroenterol | year= 2005 | volume= 100 | issue= 10 | pages= 2324-37 | pmid=16181387 | doi=10.1111/j.1572-0241.2005.00225.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16181387  }} </ref>
**[[Liver function tests]]
 
**Serum [[lipase]] and [[amylase]]
The methods of diagnostic testing for ''H. pylori'' can be classified into invasive and non-invasive tests:<ref name="pmid17608775">{{cite journal| author=Chey WD, Wong BC, Practice Parameters Committee of the American College of Gastroenterology| title=American College of Gastroenterology guideline on the management of Helicobacter pylori infection. | journal=Am J Gastroenterol | year= 2007 | volume= 102 | issue= 8 | pages= 1808-25 | pmid=17608775 | doi=10.1111/j.1572-0241.2007.01393.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17608775  }} </ref><ref name="pmid8855734">{{cite journal |vauthors=Thijs JC, van Zwet AA, Thijs WJ, Oey HB, Karrenbeld A, Stellaard F, Luijt DS, Meyer BC, Kleibeuker JH |title=Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard |journal=Am. J. Gastroenterol. |volume=91 |issue=10 |pages=2125–9 |year=1996 |pmid=8855734 |doi= |url=}}</ref>
**[[Iron]] studies
 
**Some patients with [[Peptic ulcer disease]] may have reduced serum [[ferritin]], which is usually suggestive of [[bleeding]] which requires further [[endoscopy]] to rule out [[bleeding]]
'''Invasive tests:'''
'''Patient with a family history of peptic ulcer or there is history of refractory ulcer to treatment''' :
*Endoscopy with biopsy is recommended to diagnose cancer and other  causes in patients 55 years or older, or with one or more alarm symptoms such asunexplained weight loss, progressive dysphagia, odynophagia, recurrent vomiting, family history of gastrointestinal cancer, overt gastrointestinal bleeding, abdominal mass, iron deficiency anemia, or jaundice.<ref name="pmid15480985">{{cite journal |vauthors=Lieberman D, Fennerty MB, Morris CD, Holub J, Eisen G, Sonnenberg A |title=Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository |journal=Gastroenterology |volume=127 |issue=4 |pages=1067–75 |year=2004 |pmid=15480985 |doi= |url=}}</ref><ref name="pmid16235292">{{cite journal |vauthors=Delaney B, Ford AC, Forman D, Moayyedi P, Qume M |title=Initial management strategies for dyspepsia |journal=Cochrane Database Syst Rev |volume= |issue=4 |pages=CD001961 |year=2005 |pmid=16235292 |doi=10.1002/14651858.CD001961.pub2 |url=}}</ref><ref name="pmid154809852">{{cite journal |vauthors=Lieberman D, Fennerty MB, Morris CD, Holub J, Eisen G, Sonnenberg A |title=Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository |journal=Gastroenterology |volume=127 |issue=4 |pages=1067–75 |year=2004 |pmid=15480985 |doi= |url=}}</ref><ref name="pmid15784019">{{cite journal |vauthors=Marmo R, Rotondano G, Piscopo R, Bianco MA, Russo P, Capobianco P, Cipolletta L |title=Combination of age and sex improves the ability to predict upper gastrointestinal malignancy in patients with uncomplicated dyspepsia: a prospective multicentre database study |journal=Am. J. Gastroenterol. |volume=100 |issue=4 |pages=784–91 |year=2005 |pmid=15784019 |doi=10.1111/j.1572-0241.2005.40085.x |url=}}</ref>
*A fasting serum [[gastrin]] level can be done to screen for [[Zollinger-Ellison syndrome]]
*Patients who have not been taking a PPI within one to two weeks of endoscopy, or bismuth or an antibiotic within four weeks, the rapid urease test performed on the biopsy specimen provides an accurate
*If the diagnosis of Zollinger-Ellison syndrome cannot be made on the basis of the serum gastrin level, then next step is to measure  [[secretin]] stimulation test
*Patients who have been on these medications will require histology, with or without rapid urease testing. Culture and polymerase chain reaction allow for susceptibility testing<ref name="pmid2072790">{{cite journal |vauthors=Mamel JJ |title=Use of endoscopy in peptic ulcer disease |journal=Med. Clin. North Am. |volume=75 |issue=4 |pages=841–51 |year=1991 |pmid=2072790 |doi= |url=}}</ref>  
'''Following test can be done to document the residual infection after eradication therapy''':<ref name="pmid23551920">{{cite journal |vauthors=Korkmaz H, Kesli R, Karabagli P, Terzi Y |title=Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection |journal=Helicobacter |volume=18 |issue=5 |pages=384–91 |year=2013 |pmid=23551920 |doi=10.1111/hel.12053 |url=}}</ref><ref name="pmid11922552">{{cite journal |vauthors=Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura F |title=Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy |journal=Am. J. Gastroenterol. |volume=97 |issue=3 |pages=594–9 |year=2002 |pmid=11922552 |doi=10.1111/j.1572-0241.2002.05535.x |url=}}</ref><ref name="pmid21264478">{{cite journal |vauthors=Shimoyama T, Sawaya M, Ishiguro A, Hanabata N, Yoshimura T, Fukuda S |title=Applicability of a rapid stool antigen test, using monoclonal antibody to catalase, for the management of Helicobacter pylori infection |journal=J. Gastroenterol. |volume=46 |issue=4 |pages=487–91 |year=2011 |pmid=21264478 |doi=10.1007/s00535-011-0371-4 |url=}}</ref><ref name="pmid16091438">{{cite journal |vauthors=Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, Kocazeybek B |title=Evaluation of two enzyme immunoassays for detecting Helicobacter pylori in stool specimens of dyspeptic patients after eradication therapy |journal=J. Med. Microbiol. |volume=54 |issue=Pt 9 |pages=863–6 |year=2005 |pmid=16091438 |doi=10.1099/jmm.0.45914-0 |url=}}</ref><ref name="pmid15545164">{{cite journal |vauthors=Asfeldt AM, Løchen ML, Straume B, Steigen SE, Florholmen J, Goll R, Nestegard O, Paulssen EJ |title=Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection |journal=Scand. J. Gastroenterol. |volume=39 |issue=11 |pages=1073–7 |year=2004 |pmid=15545164 |doi=10.1080/00365520410007944 |url=}}</ref>
 
*[[Urea breath test]] (carbon 13) tests: This is used to document eradication therapy  and should be performed four to six weeks after completion of eradication therapy
{| class="wikitable"
**[[Urea breath test]] require the ingestion of [[urea]] labeled with the nonradioactive isotope carbon 13 or carbon 14
|+ Diagnostic testing for ''H. pylori'' infection
**[[Proton pump inhibitor|Proton pump inhibitors]] (PPIs) should be stopped for  two weeks before the test 
! Endoscopic testing !! Comments
*Stool monoclonal antigen tests-This detect  active [[infection]] and can be used as a test of cure
|-
**PPIs should be stopped for two weeks before testing
| Rapid urease testing || Patients who have not been on a PPI within 1-2 weeks or an antibiotic or bismuth within 4 weeks of endoscopy
**This can be done by following methods:
|-
***[[Enzyme immunoassay]]
| Histology || Patients who have been taking a PPI, antibiotics, or bismuth, endoscopic testing should include biopsies from the gastric body and antrum
***Immunochromatography
|-
***[[Antibody tests]]
|Culture and [[Polymerase Chain Reaction]] || Not routinely recommended
|}
'''Noninvasive tests''':
*Urea breath test (carbon 13) tests:Urea breath tests require the ingestion of urea labeled with the nonradioactive isotope carbon 13 or carbon 14.Proton pump inhibitors (PPIs) should be stopped for  two weeks before the test. It is used to document eradication therapy  and should be performed four to six weeks after completion of eradication therapy.  
*Stool monoclonal antigen tests- it detect  active infection and can be used as a test of cure. PPIs should be stopped for two weeks before testing.It can be done by following methods:<ref name="pmid23551920">{{cite journal |vauthors=Korkmaz H, Kesli R, Karabagli P, Terzi Y |title=Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection |journal=Helicobacter |volume=18 |issue=5 |pages=384–91 |year=2013 |pmid=23551920 |doi=10.1111/hel.12053 |url=}}</ref><ref name="pmid11922552">{{cite journal |vauthors=Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura F |title=Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy |journal=Am. J. Gastroenterol. |volume=97 |issue=3 |pages=594–9 |year=2002 |pmid=11922552 |doi=10.1111/j.1572-0241.2002.05535.x |url=}}</ref><ref name="pmid21264478">{{cite journal |vauthors=Shimoyama T, Sawaya M, Ishiguro A, Hanabata N, Yoshimura T, Fukuda S |title=Applicability of a rapid stool antigen test, using monoclonal antibody to catalase, for the management of Helicobacter pylori infection |journal=J. Gastroenterol. |volume=46 |issue=4 |pages=487–91 |year=2011 |pmid=21264478 |doi=10.1007/s00535-011-0371-4 |url=}}</ref><ref name="pmid16091438">{{cite journal |vauthors=Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, Kocazeybek B |title=Evaluation of two enzyme immunoassays for detecting Helicobacter pylori in stool specimens of dyspeptic patients after eradication therapy |journal=J. Med. Microbiol. |volume=54 |issue=Pt 9 |pages=863–6 |year=2005 |pmid=16091438 |doi=10.1099/jmm.0.45914-0 |url=}}</ref><ref name="pmid15545164">{{cite journal |vauthors=Asfeldt AM, Løchen ML, Straume B, Steigen SE, Florholmen J, Goll R, Nestegard O, Paulssen EJ |title=Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection |journal=Scand. J. Gastroenterol. |volume=39 |issue=11 |pages=1073–7 |year=2004 |pmid=15545164 |doi=10.1080/00365520410007944 |url=}}</ref>
**Enzyme immunoassay
**Immunochromatography
**Antibody tests
 
{| class="wikitable"
|+ Diagnostic testing for ''H. pylori'' infection
! Nonendoscopic testing !! Comments
|-
| Urea breath tests || Provide reliable means of identifying active ''H. pylori infection'' before antibiotic treatment and is the most reliable nonendoscopic test to document eradication of infection
|-
| Serological testing || Limited use in low prevalence ''H. pylori'' populations
|-
| Stool monoclonal antigen
* Enzyme immunoassay
* Immunochromatography
* Antibody tests
|  Used to detect active infection  and can be used  to document eradication of infection
|}
 
*The possibility of other causes of ulcers, notably [[malignancy]] ([[gastric cancer]]) needs to be kept in mind. This is especially true in ulcers of the ''greater (large) curvature'' of the [[stomach]]; most are also a consequence of chronic ''H. pylori'' infection.
*Esophagogastroduodenoscopy: indicated in patients >55 years, those whose symptoms do not respond to medications, those with alarm symptoms (bleeding, weight loss, chronicity, persistent vomiting.<ref name="pmid17956071">{{cite journal| author=Ramakrishnan K, Salinas RC| title=Peptic ulcer disease. | journal=Am Fam Physician | year= 2007 | volume= 76 | issue= 7 | pages= 1005-12 | pmid=17956071 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17956071  }} </ref>


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Primary care]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 23:37, 29 July 2020

Peptic ulcer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peptic Ulcer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Upper GI Endoscopy

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Endoscopic management
Surgical management

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

2017 ACG Guidelines for Peptic Ulcer Disease

Guidelines for the Indications to Test for, and to Treat, H. pylori Infection

Guidelines for First line Treatment Strategies of Peptic Ulcer Disease for Providers in North America

Guidlines for factors that predict the successful eradication when treating H. pylori infection

Guidelines to document H. pylori antimicrobial resistance in the North America

Guidelines for evaluation and testing of H. pylori antibiotic resistance

Guidelines for when to test for treatment success after H. pylori eradication therapy

Guidelines for penicillin allergy in patients with H. pylori infection

Guidelines for the salvage therapy

Peptic ulcer laboratory tests On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peptic ulcer laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peptic ulcer laboratory tests

CDC on Peptic ulcer laboratory tests

Peptic ulcer laboratory tests in the news

Blogs on Peptic ulcer laboratory tests

to Hospitals Treating Peptic ulcer

Risk calculators and risk factors for Peptic ulcer laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2] Guillermo Rodriguez Nava, M.D. [3]

Overview

There is no specific diagnostic laboratory test for peptic ulcer disease but in the patient with the history of peptic ulcer disease, the laboratory test is used to rule out bleeding and to document the status of eradication therapy and to test refractory ulcers.

Initial Laboratory Studies

Patient with a family history of peptic ulcer or there is history of refractory ulcer to treatment :

  • A fasting serum gastrin level can be done to screen for Zollinger-Ellison syndrome
  • If the diagnosis of Zollinger-Ellison syndrome cannot be made on the basis of the serum gastrin level, then next step is to measure secretin stimulation test

Following test can be done to document the residual infection after eradication therapy:[7][8][9][10][11]

  • Urea breath test (carbon 13) tests: This is used to document eradication therapy and should be performed four to six weeks after completion of eradication therapy
  • Stool monoclonal antigen tests-This detect active infection and can be used as a test of cure

References

  1. Graham DY, Rakel RE, Fendrick AM, Go MF, Marshall BJ, Peura DA, Scherger JE (1999). "Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis". Postgrad Med. 105 (3): 113–6, 121–3, 127–8 passim. doi:10.3810/pgm.1999.03.594. PMID 10086037.
  2. Rosen SD, Rogers AI (1990). "Clinical recognition and evaluation of peptic ulcer disease". Postgrad Med. 88 (5): 42–7, 51, 55. PMID 2216988.
  3. Fashner J, Gitu AC (2015). "Diagnosis and Treatment of Peptic Ulcer Disease and H. pylori Infection". Am Fam Physician. 91 (4): 236–42. PMID 25955624.
  4. Graham DY, Rakel RE, Fendrick AM, Go MF, Marshall BJ, Peura DA, Scherger JE (1999). "Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis". Postgrad Med. 105 (3): 113–6, 121–3, 127–8 passim. doi:10.3810/pgm.1999.03.594. PMID 10086037.
  5. Chung CS, Chiang TH, Lee YC (2015). "A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers". Korean J. Intern. Med. 30 (5): 559–70. doi:10.3904/kjim.2015.30.5.559. PMC 4578017. PMID 26354049.
  6. Mehmedović-Redzepović A, Mesihović R, Prnjavorac B, Kulo A, Merlina K (2011). "Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pump inhibitors". Med Glas (Zenica). 8 (1): 151–7. PMID 21263414.
  7. Korkmaz H, Kesli R, Karabagli P, Terzi Y (2013). "Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection". Helicobacter. 18 (5): 384–91. doi:10.1111/hel.12053. PMID 23551920.
  8. Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura F (2002). "Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy". Am. J. Gastroenterol. 97 (3): 594–9. doi:10.1111/j.1572-0241.2002.05535.x. PMID 11922552.
  9. Shimoyama T, Sawaya M, Ishiguro A, Hanabata N, Yoshimura T, Fukuda S (2011). "Applicability of a rapid stool antigen test, using monoclonal antibody to catalase, for the management of Helicobacter pylori infection". J. Gastroenterol. 46 (4): 487–91. doi:10.1007/s00535-011-0371-4. PMID 21264478.
  10. Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, Kocazeybek B (2005). "Evaluation of two enzyme immunoassays for detecting Helicobacter pylori in stool specimens of dyspeptic patients after eradication therapy". J. Med. Microbiol. 54 (Pt 9): 863–6. doi:10.1099/jmm.0.45914-0. PMID 16091438.
  11. Asfeldt AM, Løchen ML, Straume B, Steigen SE, Florholmen J, Goll R, Nestegard O, Paulssen EJ (2004). "Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection". Scand. J. Gastroenterol. 39 (11): 1073–7. doi:10.1080/00365520410007944. PMID 15545164.

Template:WikiDoc Sources